ArticleNature communications2026
Regenerating end-of-life membranes for enhanced sustainability and unexpected performance.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Membrane technologies are widely adopted in water purification, gas separation, resource recovery and chemical production. However, membranes eventually reach their end-of-life (EOL) due to structural degradation and irrecoverable fouling, leading to incineration or landfilling which contradicts the sustainability and circular economy principles. Here we present a strategy to regenerate EOL membranes through dissolution in organic solvent followed by re-casting. The regenerated membrane exhibits more than fivefold higher water permeance with improved pollutant rejection compared to the EOL membrane, and even outperforms membrane fabricated from pristine polymer powders. This enhancement is attributed to the integration of residual foulants as pore-forming agents and hydrophilic additives. Moreover, the reduced entanglement density of EOL membrane improves its compatibility with solvent and foulants, enabling the formation of a dense separation layer in the regenerated membrane. This strategy achieves 38.4% lower CO
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.